Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Lindsay J. Collin, Deirdre P. Cronin-Fenton, Thomas P. Ahern, Kristina B. Christensen, Per Damkier, Stephen Hamilton-Dutoit, Anders Kjaersgaard, Kristina L. Lauridsen, Rami Yacoub, Peer Christiansen, Henrik Toft Sørensen & Timothy L. Lash. (2019) Expression of survivin does not appear to influence breast cancer recurrence risk. Acta Oncologica 58:2, pages 154-161.
Read now
Read now
Maj-Britt Jensen, Anne-Vibeke Laenkholm, Birgitte V. Offersen, Peer Christiansen, Niels Kroman, Henning T. Mouridsen & Bent Ejlertsen. (2018) The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016. Acta Oncologica 57:1, pages 13-18.
Read now
Read now
Thomas P. Ahern, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen, Anne Gulbech Ording, Stephen J. Hamilton-Dutoit & Ylva Hellberg. (2016) Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study. Acta Oncologica 55:6, pages 734-741.
Read now
Read now
Waseem Asim Ghulam El-Charnoubi, Jesper Brink Svendsen, Ulla Brix Tange & Niels Kroman. (2012) Women with inoperable or locally advanced breast cancer – what characterizes them? A retrospective review of 157 cases. Acta Oncologica 51:8, pages 1081-1085.
Read now
Read now
Susanne Møller, Maj-Britt Jensen, Bent Ejlertsen, Karsten D. Bjerre, Martin Larsen, Hanne B. Hansen, Peer Christiansen & Henning T. Mouridsen. (2008) The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncologica 47:4, pages 506-524.
Read now
Read now
Henrik W. Kiaer, Anne-Vibeke Laenkholm, Bernt B. Nielsen & Karsten D. Bjerre. (2008) Classical pathological variables recorded in the Danish Breast Cancer Cooperative Group's register 1978–2006. Acta Oncologica 47:4, pages 778-783.
Read now
Read now
Marianne Ewertz, Mette Moe Kempel, Maria Düring, Maj-Britt Jensen, Michael Andersson, Peer Christiansen, Niels Kroman, Birgitte Bruun Rasmussen & Marie Overgaard. (2008) Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.. Acta Oncologica 47:4, pages 682-690.
Read now
Read now
Bent Ejlertsen, Maj-Britt Jensen, Henning T. Mouridsen, Jørn Andersen, Søren Cold, Erik Jakobsen, Claus Kamby, Peter G. Sørensen & Marianne Ewertz. (2008) DBCG trial 89B comparing adjuvant CMF and ovarian ablation: Similar outcome for eligible but non-enrolled and randomized breast cancer patients. Acta Oncologica 47:4, pages 709-717.
Read now
Read now
Bent Ejlertsen, Henning T. Mouridsen & Maj-Britt Jensen. (2008) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: Indirect comparison of dose and schedule in DBCG trials 77, 82, and 89. Acta Oncologica 47:4, pages 662-671.
Read now
Read now
Anni Ravnsbæk Jensen, Anders Husted Madsen & Jens Overgaard. (2008) Trends in breast cancer during three decades in Denmark: Stage at diagnosis, surgical management and survival. Acta Oncologica 47:4, pages 537-544.
Read now
Read now
Kristina Strålman, Charlotte L. Mollerup, Ulrik S. Kristoffersen & Jens J. Elberg. (2008) Long-term outcome after mastectomy with immediate breast reconstruction. Acta Oncologica 47:4, pages 704-708.
Read now
Read now
Per Syrak Hansen, Erik Andersen, Knud West Andersen & Henning T. Mouridsen. (1997) Quality Control of End Results in a Danish Adjuvant Breast Cancer Multi-Center Study. Acta Oncologica 36:7, pages 711-714.
Read now
Read now
Pia Afzelius, Karin Zedeler, Hanne Sommer, Henning T. Mouridsen & Mogens Blichert-Toft. (1994) Patient's and Doctor's Delay in Primary Breast Cancer: Prognostic implications. Acta Oncologica 33:4, pages 345-351.
Read now
Read now
K. Zedeler. (1988) Assessment and Presentation of Survival Experience in the Danish Breast Cancer Cooperative Group. Acta Oncologica 27:6, pages 649-662.
Read now
Read now
Articles from other publishers (64)
Julie Aarestrup, Lise G. Bjerregaard, Kathrine D. Meyle, Dorthe C. Pedersen, Line K. Gjærde, Britt W. Jensen & Jennifer L. Baker. (2020) Birthweight, childhood overweight, height and growth and adult cancer risks: a review of studies using the Copenhagen School Health Records Register. International Journal of Obesity 44:7, pages 1546-1560.
Crossref
Crossref
Thomas P. Ahern, Lindsay J. Collin, James W. Baurley, Anders Kjærsgaard, Rebecca Nash, Maret L. Maliniak, Per Damkier, Michael E. Zwick, R. Benjamin Isett, Peer M. Christiansen, Bent Ejlertsen, Kristina L. Lauridsen, Kristina B. Christensen, Rebecca A. Silliman, Henrik Toft Sørensen, Trine Tramm, Stephen Hamilton-Dutoit, Timothy L. Lash & Deirdre Cronin-Fenton. (2020) Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients. Cancer Epidemiology, Biomarkers & Prevention 29:3, pages 582-590.
Crossref
Crossref
Julie Louise Munk Andersen, Louise Hansen, Birthe Lykke Riegels Thomsen, Lisa Rudolph Christiansen, Lars Ove Dragsted & Anja Olsen. (2019) Pre- and post-diagnostic intake of whole grain and dairy products and breast cancer prognosis: the Danish Diet, Cancer and Health cohort. Breast Cancer Research and Treatment 179:3, pages 743-753.
Crossref
Crossref
Kristen D. Brantley, Anders Kjærsgaard, Deirdre Cronin-Fenton, Rami Yacoub, Anja S. Nielsen, Kristina L. Lauridsen, Stephen Hamilton-Dutoit & Timothy L. Lash. (2018) Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence. Cancer Epidemiology, Biomarkers & Prevention 27:6, pages 653-659.
Crossref
Crossref
Laura Schärfe Jensen, Charlotte Overgaard, Henrik Bøggild, Jens Peter Garne, Thomas Lund, Kim Overvad & Kirsten Fonager. (2017) The long-term financial consequences of breast cancer: a Danish registry-based cohort study. BMC Public Health 17:1.
Crossref
Crossref
Marianne Holm, Anja Olsen, Jane Christensen, Niels T. Kroman, Pernille E. Bidstrup, Christoffer Johansen, Kim Overvad & Anne Tjønneland. (2012) Pre‐diagnostic alcohol consumption and breast cancer recurrence and mortality: Results from a prospective cohort with a wide range of variation in alcohol intake. International Journal of Cancer 132:3, pages 686-694.
Crossref
Crossref
Gitte Bjørn Hvilsom, Lisbet Rosenkrantz Hölmich, Marianne Steding-Jessen, Kirsten Frederiksen, Trine Foged Henriksen, Loren Lipworth, Joseph McLaughlin, Jens Jørgen Elberg, Tine Engberg Damsgaard & Søren Friis. (2012) Delayed Breast Implant Reconstruction. Annals of Plastic Surgery 68:3, pages 246-252.
Crossref
Crossref
Birger Hjørland. (2011) Evaluation of an information source illustrated by a case study: Effect of screening for breast cancer. Journal of the American Society for Information Science and Technology 62:10, pages 1892-1898.
Crossref
Crossref
Abenaa M. Brewster, Gabriel N. Hortobagyi, Kristine R. Broglio, Shu-Wan Kau, Cesar A. Santa-Maria, Banu Arun, Aman U. Buzdar, Daniel J. Booser, Vincente Valero, Melissa Bondy & Francisco J. Esteva. (2008) Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant
Therapy. JNCI: Journal of the National Cancer Institute 100:16, pages 1179-1183.
Crossref
Crossref
T L Lash, L Pedersen, D Cronin-Fenton, T P Ahern, C L Rosenberg, K L Lunetta, R A Silliman, S Hamilton-Dutoit, J P Garne, M Ewertz & H T Sørensen. (2008) Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. British Journal of Cancer 99:4, pages 616-621.
Crossref
Crossref
Lisbet Rosenkrantz Hölmich, Maria Düring, Trine Foged Henriksen, Christen Krag, Ulla Brix Tange, Kim Kjøller, Joseph K. McLaughlin, Jørgen H. Olsen & Søren Friis. (2008) Delayed Breast Reconstruction With Implants After Invasive Breast Cancer Does Not Impair Prognosis. Annals of Plastic Surgery 61:1, pages 11-18.
Crossref
Crossref
S Christensen, L Pedersen, M Grijota, J B Kornum, A Beiderbeck & H T Sørensen. (2008) Incidence of interstitial pneumonitis among breast cancer patients: a 10-year Danish population-based cohort study. British Journal of Cancer 98:11, pages 1870-1875.
Crossref
Crossref
Søren Friis, Lars Thomassen, Henrik T. Sørensen, Anne Tjønneland, Kim Overvad, Deirdre P. Cronin-Fenton, Ulla Vogel, Joseph K. McLaughlin, William J. Blot & Jørgen H. Olsen. (2008) Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. European Journal of Cancer Prevention 17:2, pages 88-96.
Crossref
Crossref
Niels Bentzon, Maria Düring, Birgitte Bruun Rasmussen, Henning Mouridsen & Niels Kroman. (2007) Prognostic effect of estrogen receptor status across age in primary breast cancer. International Journal of Cancer 122:5, pages 1089-1094.
Crossref
Crossref
Thomas P. Ahern, Heidi Larsson, Jens Peter Garne, Deirdre P. Cronin-Fenton, Henrik Toft Sørensen & Timothy L. Lash. (2007) Trends in breast-conserving surgery in Denmark, 1982–2002. European Journal of Epidemiology 23:2, pages 109-114.
Crossref
Crossref
Susanne Oksbjerg Dalton, Lone Ross, Maria Düring, Kathrine Carlsen, Preben Bo Mortensen, John Lynch & Christoffer Johansen. (2007) Influence of socioeconomic factors on survival after breast cancer—A nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. International Journal of Cancer 121:11, pages 2524-2531.
Crossref
Crossref
C K Axelsson, H T Mouridsen, M Düring & S Møller. (2007) Axillary staging during surgery for breast cancer. British Journal of Surgery 94:3, pages 304-309.
Crossref
Crossref
C.T.C. Arsene & P.J.G. Lisboa. 2007. Outcome Prediction in Cancer. Outcome Prediction in Cancer
191
239
.
S O Dalton, M Düring, L Ross, K Carlsen, P B Mortensen, J Lynch & C Johansen. (2006) The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999. British Journal of Cancer 95:5, pages 653-659.
Crossref
Crossref
Nete Munk Nielsen, Klaus Rostgaard, Søren Rasmussen, Nils Koch‐Henriksen, Hans H. Storm, Mads Melbye & Henrik Hjalgrim. (2005) Cancer risk among patients with multiple sclerosis: A population‐based register study. International Journal of Cancer 118:4, pages 979-984.
Crossref
Crossref
J H Eickhoff & J Andersen. (1991) Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. British Journal of Surgery 78:11, pages 1358-1361.
Crossref
Crossref
S Cold, M Düring, M Ewertz, A Knoop & S Møller. (2005) Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). British Journal of Cancer 93:6, pages 627-632.
Crossref
Crossref
Hanne Melgaard Nielsen, Jens Overgaard, Cai Grau, Jens Juul Christensen & Marie Overgaard. (2005) Audit of the radiotherapy in the DBCG 82 b&c trials—A validation study of the 1538 patients randomised to postmastectomy radiotherapy. Radiotherapy and Oncology 76:3, pages 285-292.
Crossref
Crossref
Sidse Ørnbjerg Würtz, Ib Jarle Christensen, Anne-Sofie Schrohl, Henning Mouridsen, Ulrik Lademann, Vibeke Jensen & Nils Brünner. (2005) Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients*. Molecular & Cellular Proteomics 4:4, pages 483-491.
Crossref
Crossref
Helle Gyldenvang, Birgitte Goldsmith Mertz & Lena Ankerson. (2005) Quality management—improving the clinical pathway for breast cancer patients. European Journal of Oncology Nursing 9:1, pages 79-82.
Crossref
Crossref
S Hansen, F B Sorensen, W Vach, D A Grabau, M Bak & C Rose. (2004) Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44:5, pages 428-436.
Crossref
Crossref
L.H. Christensen, G. Engholm, J. Ceberg, S. Hein, R. Perfekt, U.B. Tange, M. Andersson, H.T. Mouridsen, T. Möller & H.H. Storm. (2004) Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?—A population-based study. European Journal of Cancer 40:8, pages 1233-1243.
Crossref
Crossref
Jan Wohlfahrt, Fritz Rank, Niels Kroman & Mads Melbye. (2004) A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. International Journal of Cancer 108:5, pages 750-753.
Crossref
Crossref
Niels Kroman, Helle Holtveg, Jan Wohlfahrt, Maj‐Britt Jensen, Henning T. Mouridsen, Mogens Blichert‐Toft & Mads Melbye. (2004) Effect of breast‐conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 100:4, pages 688-693.
Crossref
Crossref
S Holck, H Galatius, U Engel, F Wagner & J Hoffmann. (2004) False-negative frozen section of sentinel lymph node biopsy for breast cancer. The Breast 13:1, pages 42-48.
Crossref
Crossref
Martin Ahlgren, Thorkild Sørensen, Jan Wohlfahrt, Ágústa Haflidadóttir, Claus Holst & Mads Melbye. (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. International Journal of Cancer 107:6, pages 997-1000.
Crossref
Crossref
Helga Gimbel, Vibeke Zobbe, Birthe Margrethe Andersen, Thomas Filtenborg, Christian Gluud & Ann Tabor. (2003) Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG: An International Journal of Obstetrics and Gynaecology 110:12, pages 1088-1098.
Crossref
Crossref
A.R. Jensena, M. Ewertz, S. Cold, H.H. Storm & J. Overgaard. (2003) Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. European Journal of Cancer 39:12, pages 1783-1793.
Crossref
Crossref
Niels Kroman, Jan Wohlfahrt, Henning T. Mouridsen & Mads Melbye. (2003) Influence of tumor location on breast cancer prognosis. International Journal of Cancer 105:4, pages 542-545.
Crossref
Crossref
Anne-Sofie Schrohl, Ib Jarle Christensen, Anders N. Pedersen, Vibeke Jensen, Henning Mouridsen, Gillian Murphy, John A. Foekens, Nils Bruünner & Mads Nikolaj Holten-Andersen. (2003) Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer. Molecular & Cellular Proteomics 2:3, pages 164-172.
Crossref
Crossref
L R Hölmich, L Mellemkjær, K A Gunnarsdóttir, U B Tange, C Krag, S Møller, J K McLaughlin & J H Olsen. (2003) Stage of breast cancer at diagnosis among women with cosmetic breast implants. British Journal of Cancer 88:6, pages 832-838.
Crossref
Crossref
S Hansen, J Overgaard, C Rose, Ann Knoop, A-V Lænkholm, J Andersen, F B Sørensen & P A Andreasen. (2003) Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients. British Journal of Cancer 88:1, pages 102-108.
Crossref
Crossref
A R Jensen, J Overgaard & H H Storm. (2002) Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. European Journal of Cancer Prevention 11:4, pages 359-364.
Crossref
Crossref
Nete Munk Nielsen, Jan Wohlfahrt, Peter Aaby, Henrik Hjalgrim, Carsten B. Pedersen, Dorthe S. Askgaard & Mads Melbye. (2001) Cancer risk in a cohort of polio patients. International Journal of Cancer 92:4, pages 605-608.
Crossref
Crossref
D.Aa. Grabau, S.M. Thorpe, A. Knoop, W. Vach, H.D. Schrøder, M. Blichert-Toft, N.N. Al-Suliman, H.P. Graversen & C. Rose. (2000) Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients. The Breast 9:4, pages 208-217.
Crossref
Crossref
Inger Højris, Niels Peter Rønnow Sand, Jørn Andersen, Michael Rehling & Marie Overgaard. (2000) Myocardial perfusion imaging in breast cancer patients treated with or without post-mastectomy radiotherapy. Radiotherapy and Oncology 55:2, pages 163-172.
Crossref
Crossref
N Kroman, SM Thorpe, J Wohlfahrt, KW Andersen & HT Mouridsen. (2000) Variations in prognostic factors in primary breast cancer throughout the menstrual cycle. European Journal of Surgical Oncology (EJSO) 26:1, pages 11-16.
Crossref
Crossref
S Hansen, D A Grabau, F B Sørensen, M Bak, W Vach & C Rose. (2000) Vascular grading of angiogenesis: prognostic significance in breast cancer. British Journal of Cancer 82:2, pages 339-347.
Crossref
Crossref
M. Andersson, C. Kamby, M.-B. Jensen, H. Mouridsen, B. Ejlertsen, P. Dombernowsky, C. Rose, S. Cold, M. Overgaard, J. Andersen & M. Kjær. (1999) Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial. European Journal of Cancer 35:12, pages 1659-1666.
Crossref
Crossref
Inger Højris, Marie Overgaard, Jens Juul Christensen & Jens Overgaard. (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. The Lancet 354:9188, pages 1425-1430.
Crossref
Crossref
Jan Wohlfahrt, Per Kragh Andersen & Mads Melbye. (1999) Multivariate competing risks. Statistics in Medicine 18:9, pages 1023-1030.
Crossref
Crossref
Marie Overgaard, Maj-Britt Jensen, Jens Overgaard, Per S Hansen, Carsten Rose, Michael Andersson, Claus Kamby, Mogens Kjaer, Carl C Gadeberg, Birgitte Bruun Rasmussen, Mogens Blichert-Toft & Henning T Mouridsen. (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. The Lancet 353:9165, pages 1641-1648.
Crossref
Crossref
Jan Wohlfahrt, Henning Mouridsen, Per Kragh Andersen & Mads Melbye. (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. International Journal of Cancer 81:1, pages 49-55.
Crossref
Crossref
D.Aa. Grabau, M.-B. Jensen, M. Blichert-Toft, J.A. Andersen, U. Dyreborg, B. Carstensen, N.N. Al-Suliman, H.P. Graversen & C. Rose. (1998) The importance of surgery and accurate axillary staging for survival in breast cancer. European Journal of Surgical Oncology (EJSO) 24:6, pages 499-507.
Crossref
Crossref
LISE PEDERSEN. (2011) Medullary Carcinoma of the Breast. APMIS 105:S75, pages 5-31.
Crossref
Crossref
Marie Overgaard, Per S. Hansen, Jens Overgaard, Carsten Rose, Michael Andersson, Flemming Bach, Mogens Kjaer, Carl C. Gadeberg, Henning T. Mouridsen, Maj-Britt Jensen & Karin Zedeler. (1997) Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy. New England Journal of Medicine 337:14, pages 949-955.
Crossref
Crossref
Niels Kroman, Maj-Britt Jensen, Mads Melbye, Jan Wohlfahrt & Henning T Mouridsen. (1997) Should women be advised against pregnancy after breast-cancer treatment?. The Lancet 350:9074, pages 319-322.
Crossref
Crossref
L. Pedersen, K. Zedeler, S. Holck, T. Schiødt & H.T. Mouridsen. (1995) Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. European Journal of Cancer 31:13-14, pages 2289-2295.
Crossref
Crossref
Morten Ladekarl. (1995) Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts. Cancer 75:8, pages 2114-2122.
Crossref
Crossref
T. Haerslev, Krag Jacobsen, L. Nedergaard & K. Zedeler. (1994) Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Pathology - Research and Practice 190:7, pages 675-681.
Crossref
Crossref
S. Holck, L. Pedersen, T. Schiødt, K. Zedeler & H. Mouridsen. (1993) Vimentin expression in 98 breast cancers with medullary features and its prognostic significance. Virchows Archiv A Pathological Anatomy and Histopathology 422:6, pages 475-479.
Crossref
Crossref
S.M. Thorpe, I.J. Christensen, B.B. Rasmussen & C. Rose. (1993) Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. European Journal of Cancer 29:7, pages 971-977.
Crossref
Crossref
Christen K. Axelsson, Henning T. Mouridsen & Karin Zedeler. (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. European Journal of Cancer 28:8-9, pages 1415-1418.
Crossref
Crossref
Philippa J. Easterbrook. (1992) Directory of registries of clinical trials. Statistics in Medicine 11:3, pages 345-423.
Crossref
Crossref
Karin Zedeler, Niels Keiding & Claus Kamby. (1992) Differential influence of prognostic factors on the occurrence of metastases at various anatomical sites in human breast cancer. Statistics in Medicine 11:3, pages 281-294.
Crossref
Crossref
M. Overgaard, J. Juul Christensen, H. Johansen, A. Nybo-Rasmussen, C. Rose, P. van der Kooy, J. Panduro, F. Laursen, M. Kjær, N.E. Sørensen, C.C. Gadeberg, M. Hjelm-Hansen, J. Overgaard, K. West Andersen & K. Zedeler. (1990) Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial. International Journal of Radiation Oncology*Biology*Physics 19:5, pages 1121-1124.
Crossref
Crossref
Marianne Ewertz. (1990) Smoking and breast cancer risk in Denmark. Cancer Causes and Control 1:1, pages 31-37.
Crossref
Crossref
Vebeke B. Løgager, Aage Vestergaard, Jørn Herrstedt, Henrik S. Thomsen, Karin Zedeler & Per Dombernowsky. (1990) The limited value of routine chest X-ray in the follow-up of stage II breast cancer. European Journal of Cancer and Clinical Oncology 26:5, pages 553-555.
Crossref
Crossref
Ingegerd Balslev, Karin Zedeler, Susan M. Thorpe, Birgitte Bruun Rasmussen & Henning T. Mouridsen. 1990. Endocrine Therapy of Breast Cancer IV. Endocrine Therapy of Breast Cancer IV
31
41
.